Evidence map›Paper›PMID 19764817›Full record

ArticleBiochemistry2009

Structure and inhibition of human diamine oxidase.

Aaron P McGrath, Kimberly M Hilmer, Charles A Collyer, Eric M Shepard, Bradley O Elmore, Doreen E Brown, David M Dooley, J Mitchell Guss

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Review
  3. Recombinant human diamine oxidase prevents histamine-induced hypoxia, shock and death in guinea pigs.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. A Diamine Oxidase fromFoods (Basel, Switzerland) · 2025
    Article
  9. Article
  10. COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated ThInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  11. Article
  12. Histamine Promotes Pseudomonas aeruginosa Biofilm Formation and Renders P. aeruginosa Biofilms More Resistant to Gentamicin and Azithromycin.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Enzymatic reactions towards aldehydes: An overview.Flavour and fragrance journal · 2023
    Review
  17. Review
  18. Review
  19. Review
  20. How "Neuronal" Are Human Skin Mast Cells?International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Aaron P McGrathSchool of Molecular and Microbial Biosciences, University of Sydney, Sydney, NSW 2006, Australia.
Kimberly M Hilmer
Charles A Collyer
Eric M Shepard
Bradley O Elmore
Doreen E Brown
David M Dooley
J Mitchell Guss
Montana State University · USUniversity of Sydney · AUUniversity of Rhode Island · US

Funding

Structures, Mechanisms, and Biogenesis of Amine OxidasesR01GM027659 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI DOOLEY, DAVID M. · 1985 to 2009
$2.9M
NIGMS NIH HHS GM 27659NIGMS NIH HHS R01 GM027659
6 · The paper itself

Abstract

Humans have three functioning genes that encode copper-containing amine oxidases. The product of the AOC1 gene is a so-called diamine oxidase (hDAO), named for its substrate preference for diamines, particularly histamine. hDAO has been cloned and expressed in insect cells and the structure of the native enzyme determined by X-ray crystallography to a resolution of 1.8 A. The homodimeric structure has the archetypal amine oxidase fold. Two active sites, one in each subunit, are characterized by the presence of a copper ion and a topaquinone residue formed by the post-translational modification of a tyrosine. Although hDAO shares 37.9% sequence identity with another human copper amine oxidase, semicarbazide sensitive amine oxidase or vascular adhesion protein-1, its substrate binding pocket and entry channel are distinctly different in accord with the different substrate specificities. The structures of two inhibitor complexes of hDAO, berenil and pentamidine, have been refined to resolutions of 2.1 and 2.2 A, respectively. They bind noncovalently in the active-site channel. The inhibitor binding suggests that an aspartic acid residue, conserved in all diamine oxidases but absent from other amine oxidases, is responsible for the diamine specificity by interacting with the second amino group of preferred diamine substrates.

Indexed as

Amine Oxidase (Copper-Containing)AnimalsBinding SitesCalciumCopperCrystallography, X-RayDimerizationDiminazeneDrosophilaHumansKineticsMetallothioneinModels, MolecularPentamidinePromoter Regions, GeneticProtein ConformationAmine Oxidase (Copper-Containing)CalciumCopperDiminazenediminazene aceturateMetallothioneinPentamidine

Identifiers

PMID19764817
PMCPMC2791411
OpenAlexW2080454705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.